Azenta, INC 8-K filings

NASDAQ

31 Jan 2024

AZTA

8-K: Azenta, Inc. Realigns Business Segments to Drive Growth and Profitability

Azenta, Inc. has reorganized its business into three segments: Multiomics, Sample Management Solutions, and B Medical Systems, effective October 1, 2023, to enhance its commercial strategy and profitability.

NASDAQ

17 Jan 2024

AZTA

Azenta, INC

8-K: Azenta Inc. Director Ellen M. Zane to Depart Board at 2024 Annual Meeting

Ellen M. Zane will not seek re-election to Azenta Inc.'s Board of Directors at the upcoming 2024 Annual Meeting, reducing the board size to nine members.